Publications by authors named "Adele Williams"

Claim this Profile
A
AI in practice: the quiet rise of BYO tools.
Adele Williams

Vet Rec· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI in veterinary medicine: where to start and what's new?
Adele Williams

Vet Rec· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors.
Colin H Quinn, Andee M Beierle, Adele P Williams, Raoud Marayati, Laura V Bownes

Transl Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Telemedicine has a valid place in a modern veterinary profession'.
Adele Williams

Vet Rec· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pediatric case of xanthogranulomatous pyelonephritis in the setting of Covid-19 and multi-system inflammatory syndrome (MIS-C).
Janet R Julson, M D Sibat Noor, Adele P Williams, Jason Wicker, Elizabeth A Beierle

J Pediatr Surg Case Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype.
Raoud Marayati, Janet R Julson, Laura V Bownes, Colin H Quinn, Sara C Hutchins, Adele P Williams

J Pediatr Surg· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.
Raoud Marayati, Laura L Stafman, Adele P Williams, Laura V Bownes, Colin H Quinn

Cancer Gene Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.
Laura V Bownes, Adele P Williams, Raoud Marayati, Laura L Stafman, Hooper Markert

PLoS One· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor.
Colin H Quinn, Andee M Beierle, Adele P Williams, Raoud Marayati, Laura V Bownes

Transl Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
Raoud Marayati, Laura V Bownes, Colin H Quinn, Nikita Wadhwani, Adele P Williams

J Pediatr Surg· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.
Laura V Bownes, Adele P Williams, Raoud Marayati, Colin H Quinn, Sara C Hutchins

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
Raoud Marayati, Laura L Stafman, Adele P Williams, Laura V Bownes, Colin H Quinn

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
Raoud Marayati, Laura V Bownes, Laura L Stafman, Adele P Williams, Colin H Quinn

Transl Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
Raoud Marayati, Adele P Williams, Laura V Bownes, Colin H Quinn, Jerry E Stewart

J Pediatr Surg· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features.
Anna Hoppmann, Adele P Williams, Aubrey Coleman, Clay Tynes, Grant R Williams

Pediatr Blood Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
Laura L Stafman, Adele P Williams, Raoud Marayati, Jamie M Aye, Jerry E Stewart

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corruption of neuroblastoma patient derived xenografts with human T cell lymphoma.
Adele P Williams, Jerry E Stewart, Laura L Stafman, Jamie M Aye, Elizabeth Mroczek-Musulman

J Pediatr Surg· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
Adele P Williams, Evan F Garner, Laura L Stafman, Jamie M Aye, Colin H Quinn

Transl Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
Laura L Stafman, Adele P Williams, Raoud Marayati, Jamie M Aye, Hooper R Markert

Sci Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.
Jamie M Aye, Laura L Stafman, Adele P Williams, Evan F Garner, Jerry E Stewart

Oncotarget· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.
Laura L Stafman, Mary G Waldrop, Adele P Williams, Jamie M Aye, Jerry E Stewart

J Pediatr Surg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentalogy of Cantrell.
Adele P Williams, Raoud Marayati, Elizabeth A Beierle

Semin Pediatr Surg· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma.
Laura L Stafman, Adele P Williams, Evan F Garner, Jamie M Aye, Jerry E Stewart

Transl Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.
Adele P Williams, Evan F Garner, Alicia M Waters, Laura L Stafman, Jamie M Aye

Transl Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
Evan F Garner, Laura L Stafman, Adele P Williams, Jamie M Aye, Caroline Goolsby

J Neurooncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis